| Dr Sarah Lee Berga, MD | |
|
1001 Main Street, 4th Floor, Buffalo, NY 14203 | |
| (716) 636-8284 | |
| Not Available |
| Full Name | Dr Sarah Lee Berga |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 44 Years |
| Location | 1001 Main Street, Buffalo, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124054218 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Gynecologists And Obstetricians,inc. | 5597661702 | 10 |
| Kaleida Health | 7810805280 | 173 |
News Archive
Melbourne researchers have revealed how melanoma cells are flooded with DNA changes as this skin cancer progresses from early, treatable stages through to fatal end-stage disease.
Increased low-grade inflammation in the body resulting from obesity is widely viewed as contributing to type 2 diabetes. Going against this long-held belief, researchers from Children's Hospital Boston report that two proteins activated by inflammation are actually crucial for maintaining good blood sugar levels - and that boosting the activity of these proteins can normalize blood sugar in severely obese and diabetic mice.
A team of researchers led by a University of Colorado School of Medicine faculty member found that measures to evaluate readmission rates at children's hospitals would be more accurate if the social factors of the patients are included.
Based on its recent analysis of the pharmaceutical drug delivery industry, Frost & Sullivan recognizes Acino Pharma AG with the 2014 Europe Frost & Sullivan Award for Enabling Technology Leadership. Acino's expertise in targeted drug release profiles and strong technical know-how in pellet-coating, transdermal therapeutic patches and biodegradable implants has made it the preferred vendor in contract manufacturing.
An article recently published in The Lancet reports that using an artificial pancreas system overnight can significantly reduce the risk of nocturnal hypoglycemia in children and adolescents with type 1 diabetes. Moreover, the first clinical trial of an artificial pancreas system delivering both insulin and glucagon has shown that this system can prevent development of hypoglycemia.
› Verified 2 days ago
| Entity Name | Kaleida Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366473183 PECOS PAC ID: 7810805280 Enrollment ID: O20031105000212 |
News Archive
Melbourne researchers have revealed how melanoma cells are flooded with DNA changes as this skin cancer progresses from early, treatable stages through to fatal end-stage disease.
Increased low-grade inflammation in the body resulting from obesity is widely viewed as contributing to type 2 diabetes. Going against this long-held belief, researchers from Children's Hospital Boston report that two proteins activated by inflammation are actually crucial for maintaining good blood sugar levels - and that boosting the activity of these proteins can normalize blood sugar in severely obese and diabetic mice.
A team of researchers led by a University of Colorado School of Medicine faculty member found that measures to evaluate readmission rates at children's hospitals would be more accurate if the social factors of the patients are included.
Based on its recent analysis of the pharmaceutical drug delivery industry, Frost & Sullivan recognizes Acino Pharma AG with the 2014 Europe Frost & Sullivan Award for Enabling Technology Leadership. Acino's expertise in targeted drug release profiles and strong technical know-how in pellet-coating, transdermal therapeutic patches and biodegradable implants has made it the preferred vendor in contract manufacturing.
An article recently published in The Lancet reports that using an artificial pancreas system overnight can significantly reduce the risk of nocturnal hypoglycemia in children and adolescents with type 1 diabetes. Moreover, the first clinical trial of an artificial pancreas system delivering both insulin and glucagon has shown that this system can prevent development of hypoglycemia.
› Verified 2 days ago
| Entity Name | University Gynecologists & Obstetricians,inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154354140 PECOS PAC ID: 5597661702 Enrollment ID: O20031209000733 |
News Archive
Melbourne researchers have revealed how melanoma cells are flooded with DNA changes as this skin cancer progresses from early, treatable stages through to fatal end-stage disease.
Increased low-grade inflammation in the body resulting from obesity is widely viewed as contributing to type 2 diabetes. Going against this long-held belief, researchers from Children's Hospital Boston report that two proteins activated by inflammation are actually crucial for maintaining good blood sugar levels - and that boosting the activity of these proteins can normalize blood sugar in severely obese and diabetic mice.
A team of researchers led by a University of Colorado School of Medicine faculty member found that measures to evaluate readmission rates at children's hospitals would be more accurate if the social factors of the patients are included.
Based on its recent analysis of the pharmaceutical drug delivery industry, Frost & Sullivan recognizes Acino Pharma AG with the 2014 Europe Frost & Sullivan Award for Enabling Technology Leadership. Acino's expertise in targeted drug release profiles and strong technical know-how in pellet-coating, transdermal therapeutic patches and biodegradable implants has made it the preferred vendor in contract manufacturing.
An article recently published in The Lancet reports that using an artificial pancreas system overnight can significantly reduce the risk of nocturnal hypoglycemia in children and adolescents with type 1 diabetes. Moreover, the first clinical trial of an artificial pancreas system delivering both insulin and glucagon has shown that this system can prevent development of hypoglycemia.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sarah Lee Berga, MD 1001 Main Street, 4th Floor, Buffalo, NY 14203 Ph: (336) 716-2255 | Dr Sarah Lee Berga, MD 1001 Main Street, 4th Floor, Buffalo, NY 14203 Ph: (716) 636-8284 |
News Archive
Melbourne researchers have revealed how melanoma cells are flooded with DNA changes as this skin cancer progresses from early, treatable stages through to fatal end-stage disease.
Increased low-grade inflammation in the body resulting from obesity is widely viewed as contributing to type 2 diabetes. Going against this long-held belief, researchers from Children's Hospital Boston report that two proteins activated by inflammation are actually crucial for maintaining good blood sugar levels - and that boosting the activity of these proteins can normalize blood sugar in severely obese and diabetic mice.
A team of researchers led by a University of Colorado School of Medicine faculty member found that measures to evaluate readmission rates at children's hospitals would be more accurate if the social factors of the patients are included.
Based on its recent analysis of the pharmaceutical drug delivery industry, Frost & Sullivan recognizes Acino Pharma AG with the 2014 Europe Frost & Sullivan Award for Enabling Technology Leadership. Acino's expertise in targeted drug release profiles and strong technical know-how in pellet-coating, transdermal therapeutic patches and biodegradable implants has made it the preferred vendor in contract manufacturing.
An article recently published in The Lancet reports that using an artificial pancreas system overnight can significantly reduce the risk of nocturnal hypoglycemia in children and adolescents with type 1 diabetes. Moreover, the first clinical trial of an artificial pancreas system delivering both insulin and glucagon has shown that this system can prevent development of hypoglycemia.
› Verified 2 days ago
Rebeccah Stevens, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1001 Main St Fl 5, Buffalo, NY 14203 Phone: 716-323-0631 | |
Heather Michelle Link, M.D./ MPH Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 726 Exchange St, Buffalo, NY 14210 Phone: 716-208-9719 | |
Christian B Dolensek, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 219 Bryant St, Dept Of Gyn/ob, Buffalo, NY 14222 Phone: 716-878-7138 | |
Shashikant Lele, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Elm And Carlton Streets, Buffalo, NY 14263 Phone: 716-845-2300 Fax: 716-845-7608 | |
Dr. Suzanne C Griffith, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 462 Grider St, Buffalo, NY 14215 Phone: 716-898-3000 | |
Dr. Reza Askari, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 11 Summer St, Buffalo, NY 14209 Phone: 716-881-0400 Fax: 716-881-1395 | |
Dr. Joanne Sulewski, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 11 Summer St, Buffalo, NY 14209 Phone: 716-881-0400 Fax: 716-881-1395 |